XORTX Therapeutics Inc. (XRTX) reporting calendar
XORTX Therapeutics Inc. files periodic reports with the SEC as XRTX on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 20 Mar 2026
- Reports on record
- 5
Open XRTX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 20 Mar 2026 | 79 days | 0001104659-26-032775 |
| 20-F | 31 Dec 2024 | 12 May 2025 | 132 days | 0001410578-25-001183 |
| 20-F | 31 Dec 2023 | 10 May 2024 | 131 days | 0001410578-24-000737 |
| 20-F | 31 Dec 2022 | 28 Apr 2023 | 118 days | 0001410578-23-000844 |
| 20-F | 31 Dec 2021 | 3 May 2022 | 123 days | 0001753926-22-000646 |
Source: SEC EDGAR company submissions for CIK 0001729214. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.